» Articles » PMID: 29796943

Sensory Neuropathic Symptoms in Idiopathic Parkinson's Disease: Prevalence and Impact on Quality of Life

Overview
Publisher Springer
Specialty Neurology
Date 2018 May 26
PMID 29796943
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuropathic symptoms are commonly reported in Parkinson's disease (PD), but robust data on the epidemiology of such symptoms are lacking. The present study sought to investigate the prevalence and determinants of peripheral sensory neuropathic symptoms (PSNS) in idiopathic PD (IPD) and ascertain the effects of such symptoms on the patients' quality of life (QoL).

Methods: Patients with IPD and age-matched and gender-matched controls were screened for neuropathic symptoms using the Michigan Neuropathy Screening Instrument. The impact of neuropathic symptoms on QoL was investigated using the 36-Item Short Form Survey.

Results: Fifty-two patients and 52 age-matched and gender-matched controls were recruited. PSNS were reported more frequently in patients with IPD than in the control subjects (57.7 versus 28.8%, p = 0.003). No significant relationships were found between PD-related clinical characteristics (i.e. disease severity and duration, duration of exposure to levodopa) and the presence of PSNS. Significant correlations were found between the number of PSNS and physical functioning (Spearman's Rho - 0.351), even after adjusting for age, gender and Hoehn and Yahr score.

Conclusion: Our results support the notion of a greater prevalence of PSNS in IPD patients as compared to the general population, which, at least in part, may be secondary to large and/or small fibre peripheral neuropathy. This warrants further investigation in larger studies that include detailed neurophysiological assessments.

Citing Articles

Comparison of Clinical and Electrophysiologic Characteristics of Peripheral Neuropathy in Progressive Supranuclear Palsy and Parkinson's Disease: An Observational Study.

Devi Y, Kumar M, Tiwari A, Dhar M, Kumari S, Kumar N Ann Indian Acad Neurol. 2024; 28(1):72-78.

PMID: 39639527 PMC: 11892956. DOI: 10.4103/aian.aian_512_24.


Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson's Disease.

Binda K, Chacur M, Martins D Neurotox Res. 2023; 41(5):459-470.

PMID: 37266893 DOI: 10.1007/s12640-023-00651-6.


Neuropathy in Parkinson's Disease: Risk Determinants and Impact on Quality of Life.

Soumiya R, Paul B, Aggarwal R, Paul G Ann Indian Acad Neurol. 2022; 25(3):428-432.

PMID: 35936583 PMC: 9350755. DOI: 10.4103/aian.aian_902_21.


Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies.

Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari G CNS Neurosci Ther. 2020; 27(3):270-279.

PMID: 33372386 PMC: 7871788. DOI: 10.1111/cns.13549.


Mechanical Plantar Foot Stimulation in Parkinson's Disease: A Scoping Review.

Brognara L, Cauli O Diseases. 2020; 8(2).

PMID: 32397588 PMC: 7349899. DOI: 10.3390/diseases8020012.